Spiral Laminar Flow Prosthetic Bypass Graft: Medium-Term Results From a First-In-Man Structured Registry Study

被引:27
|
作者
Stonebridge, Peter A. [1 ]
Vermassen, Frank
Dick, John
Belch, Jill J. F.
Houston, Graeme
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Div Cardiovasc Res, Dundee DD1 9SY, Scotland
关键词
VASCULAR GRAFT; FEMOROPOPLITEAL BYPASS; HELICAL FLOW; BLOOD-FLOW; WALL SHEAR; VEIN; POLYTETRAFLUOROETHYLENE; PATTERNS; TRIAL; CUFF;
D O I
10.1016/j.avsg.2012.02.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: A number of surgical strategies and graft enhancements have been trialled to improve the performance of prosthetic grafts. Neointimal hyperplasia may, in part, be a normal cellular response to an abnormal (turbulent) flow environment. This first-in-many study assesses the safety and medium-term patency performance of a new graft designed to induce stable laminar flow through the distal anastomosis. Method: Forty patients who required an infrainguinal bypass graft were recruited/registered from a number of centers in Belgium and The Netherlands. Thirty-nine received a Spiral Laminar Flow graft as part of a standard treatment protocol (23 above-the-knee and 16 below-the-knee bypasses). Kaplan-Meier analyses were used to calculate primary and secondary patency rates. Results: The 12-, 24-, and 30-month primary patency rates were 86%, 81%, and 81% for above-the-knee bypasses and 73%, 57%, and 57% for below-the-knee bypasses, respectively. In the case of secondary patency rates, numbers were unchanged for above-the-knee bypasses and were 86%, 64%, and 64%, respectively, for below-the-knee bypasses. There were no amputations in the study population. Conclusion: This first-in-man series shows potential for the idea of spiral flow-enhanced prosthetic grafts. As always, randomized studies are required to explore the role of different enhanced prosthetic grafts.
引用
收藏
页码:1093 / 1099
页数:7
相关论文
共 50 条
  • [1] Medium-term outcomes of coronary artery bypass graft surgery on pump versus off pump:: Results from a randomized controlled trial
    Karolak, Wojtek
    Hirsch, Gregory
    Buth, Karen
    Legare, Jean-Francois
    AMERICAN HEART JOURNAL, 2007, 153 (04) : 689 - 695
  • [2] First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent: 12-Month Results of BiOSS LIM® Registry
    Gil, Robert J.
    Bil, Jacek
    Vassiliev, Dobrin
    Inigo Garcia, Luis A.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2015, 28 (01) : 51 - 60
  • [3] Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study
    Niewinski, Piotr
    Janczak, Dariusz
    Rucinski, Artur
    Tubek, Stanislaw
    Engelman, Zoar J.
    Piesiak, Pawel
    Jazwiec, Przemyslaw
    Banasiak, Waldemar
    Fudim, Marat
    Sobotka, Paul A.
    Javaheri, Shahrokh
    Hart, Emma C. J.
    Paton, Julian F. R.
    Ponikowski, Piotr
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (03) : 391 - 400
  • [4] Simultaneous multielectrode renal denervation treatment for resistant hypertension: results from a first-in-man feasibility study
    Whitbourn, R.
    Rothman, M.
    Walton, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 494 - 494
  • [5] First-in-man results of a novel vascular graft coated with resorbable polymer for aortic reconstructions—a multicenter, non-randomized safety study
    Zuhir Halloul
    Hartmut Rimpler
    Matthias Waliszewski
    Norbert Beier
    Frank Meyer
    Anja Rappe
    Angela Fuellert
    Joerg Tautenhahn
    Langenbeck's Archives of Surgery, 2014, 399 : 629 - 638
  • [6] Inoue stent graft implantation for TAAA involving visceral arterys: Use of branched stent graft or combination with surgical bypass: Short- to medium-term results in 15 patients
    Imai, Masao
    Kimura, Takaeshi
    Hosokawa, Hiroaki
    Odashiro, Keita
    Touma, Masanao
    Ueno, Katsuya
    Kita, Toru
    Inoue, Kanji
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 247M - 247M
  • [7] Long term results from the first-in-man application of bevacizumab-eluting stent: a novel approach for the inhibition of plaque neovascularization
    Toutouzas, K.
    Stefanadi, E.
    Karampelas, J.
    Tsiamis, E.
    Vavuranakis, M.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 12 - 12
  • [8] Long term results from the first-in-man application of bevacizumab-eluting stent: A novel approach for the inhibition of plaque neovascularization
    Toutouzas, Konstantinos
    Stefanadi, Elli
    Karahelas, John
    Drakopoulou, Maria
    Riga, Maria
    Tsiamis, Eleftherios
    Kipshidze, Nicholas
    Stefanadis, Christodoulos
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 162L - 162L
  • [9] Results from the First in Man German Pilot Study of the Silver Graft, a Vascular Graft Impregnated with Metallic Silver
    Zegelman, Max
    Guenther, Gisela
    Florek, Hans-Joachim
    Orend, Karl-Heinz
    Zuehlke, Helmut
    Liewald, Florian
    Storck, Martin
    VASCULAR, 2009, 17 (04) : 190 - 196
  • [10] Medium-term outcome with contemporary mobile-bearing implants : results from a retrospective multicentre study
    Van Parys, Michiel
    Borms, Anton
    Vundelinckx, Bart
    Bulterys, Koen
    De Schepper, Jo
    ACTA ORTHOPAEDICA BELGICA, 2020, 86 (04): : 657 - 662